Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy
Background: To enhance prostate cancer diagnosis, multiparametric Magnetic Resonance Imaging (mpMRI) combined with Transrectal Ultrasound (TRUS) fusion-guided biopsy has emerged as a promising technique. This study aimed to evaluate its clinical benefits over traditional TRUS-guided biopsy. Methods:...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MRE Press
2025-01-01
|
| Series: | Journal of Men's Health |
| Subjects: | |
| Online Access: | https://oss.jomh.org/files/article/20250124-466/pdf/JOMH2024081401.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850196306185682944 |
|---|---|
| author | Chen Ying Yongbo Wang Jianping Wang Minghuang Rao Chao Li Yongchao Wang Yujian Huang |
| author_facet | Chen Ying Yongbo Wang Jianping Wang Minghuang Rao Chao Li Yongchao Wang Yujian Huang |
| author_sort | Chen Ying |
| collection | DOAJ |
| description | Background: To enhance prostate cancer diagnosis, multiparametric Magnetic Resonance Imaging (mpMRI) combined with Transrectal Ultrasound (TRUS) fusion-guided biopsy has emerged as a promising technique. This study aimed to evaluate its clinical benefits over traditional TRUS-guided biopsy. Methods: A retrospective analysis was performed on 83 patients diagnosed between January 2022 and April 2024. Patients were divided into two groups: 41 underwent mpMRI/TRUS fusion-guided biopsy, while 42 had traditional TRUS-guided biopsy. The baseline characteristics of both groups were similar, facilitating a direct comparison of diagnostic efficacy and complication rates. Results: The fusion-guided group showed a significantly higher detection rate of clinically significant prostate cancer (21/41 vs. 12/42, p = 0.035). It also detected more clinically significant cases (20/41 vs. 11/42, p = 0.033). Notably, the fusion group experienced fewer complications, including no instances of hematochezia (p = 0.003) or infections (p = 0.012), and reported lower postoperative pain levels (Visual Analog Scale score 1.8 ± 0.78 vs. 2.33 ± 1.07, p = 0.012). Conclusions: The integration of mpMRI with TRUS in fusion-guided biopsy enhances the accuracy of detecting clinically significant prostate cancer, reduces procedural complications, and minimizes patient discomfort. This approach represents a significant advancement in prostate cancer management, improving both diagnostic outcomes and patient safety. |
| format | Article |
| id | doaj-art-772666beebbb45e1a3220bfa52653039 |
| institution | OA Journals |
| issn | 1875-6867 1875-6859 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MRE Press |
| record_format | Article |
| series | Journal of Men's Health |
| spelling | doaj-art-772666beebbb45e1a3220bfa526530392025-08-20T02:13:31ZengMRE PressJournal of Men's Health1875-68671875-68592025-01-01211818610.22514/jomh.2025.008S1875-6867(25)00325-2Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsyChen Ying0Yongbo Wang1Jianping Wang2Minghuang Rao3Chao Li4Yongchao Wang5Yujian Huang6Xiamen Haicang Hospital, 361000 Xiamen, Fujian, ChinaCixi Biomedical Research Institute, Wenzhou Medical University, 325000 Wenzhou, Zhejiang, ChinaXiamen Haicang Hospital, 361000 Xiamen, Fujian, ChinaXiamen Haicang Hospital, 361000 Xiamen, Fujian, ChinaXiamen Haicang Hospital, 361000 Xiamen, Fujian, ChinaXiamen Haicang Hospital, 361000 Xiamen, Fujian, ChinaThe First Hospital of Putian City, 351100 Putian, Fujian, ChinaBackground: To enhance prostate cancer diagnosis, multiparametric Magnetic Resonance Imaging (mpMRI) combined with Transrectal Ultrasound (TRUS) fusion-guided biopsy has emerged as a promising technique. This study aimed to evaluate its clinical benefits over traditional TRUS-guided biopsy. Methods: A retrospective analysis was performed on 83 patients diagnosed between January 2022 and April 2024. Patients were divided into two groups: 41 underwent mpMRI/TRUS fusion-guided biopsy, while 42 had traditional TRUS-guided biopsy. The baseline characteristics of both groups were similar, facilitating a direct comparison of diagnostic efficacy and complication rates. Results: The fusion-guided group showed a significantly higher detection rate of clinically significant prostate cancer (21/41 vs. 12/42, p = 0.035). It also detected more clinically significant cases (20/41 vs. 11/42, p = 0.033). Notably, the fusion group experienced fewer complications, including no instances of hematochezia (p = 0.003) or infections (p = 0.012), and reported lower postoperative pain levels (Visual Analog Scale score 1.8 ± 0.78 vs. 2.33 ± 1.07, p = 0.012). Conclusions: The integration of mpMRI with TRUS in fusion-guided biopsy enhances the accuracy of detecting clinically significant prostate cancer, reduces procedural complications, and minimizes patient discomfort. This approach represents a significant advancement in prostate cancer management, improving both diagnostic outcomes and patient safety.https://oss.jomh.org/files/article/20250124-466/pdf/JOMH2024081401.pdfmultiparametric magnetic resonance imagingtransrectal ultrasoundtransperineal prostate biopsyprostate cancer |
| spellingShingle | Chen Ying Yongbo Wang Jianping Wang Minghuang Rao Chao Li Yongchao Wang Yujian Huang Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy Journal of Men's Health multiparametric magnetic resonance imaging transrectal ultrasound transperineal prostate biopsy prostate cancer |
| title | Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy |
| title_full | Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy |
| title_fullStr | Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy |
| title_full_unstemmed | Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy |
| title_short | Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy |
| title_sort | clinical study on mpmri trus software fusion guided transperineal prostate biopsy |
| topic | multiparametric magnetic resonance imaging transrectal ultrasound transperineal prostate biopsy prostate cancer |
| url | https://oss.jomh.org/files/article/20250124-466/pdf/JOMH2024081401.pdf |
| work_keys_str_mv | AT chenying clinicalstudyonmpmritrussoftwarefusionguidedtransperinealprostatebiopsy AT yongbowang clinicalstudyonmpmritrussoftwarefusionguidedtransperinealprostatebiopsy AT jianpingwang clinicalstudyonmpmritrussoftwarefusionguidedtransperinealprostatebiopsy AT minghuangrao clinicalstudyonmpmritrussoftwarefusionguidedtransperinealprostatebiopsy AT chaoli clinicalstudyonmpmritrussoftwarefusionguidedtransperinealprostatebiopsy AT yongchaowang clinicalstudyonmpmritrussoftwarefusionguidedtransperinealprostatebiopsy AT yujianhuang clinicalstudyonmpmritrussoftwarefusionguidedtransperinealprostatebiopsy |